CI 934

Known as: CI-934 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-1989
024619851989

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
The in-vitro activities of eight new quinolones (A-56620, amifloxacin, difloxacin, CI-934, enoxacin, irloxacin, pefloxacin… (More)
Is this relevant?
1989
1989
The in vitro inhibitory effects of quinolones on the bacterial DNA gyrase of Escherichia coli KL-16 and topoisomerase II of fetal… (More)
  • table 1
Is this relevant?
1987
1987
The in vitro activity of the quinolone CI-934 was compared with ciprofloxacin, norfloxacin, enoxacin, and vancomycin against 607… (More)
Is this relevant?
1987
1987
Thirty-five clinical isolates of Mycobacterium tuberculosis, 24 susceptible and 11 resistant to conventional primary… (More)
Is this relevant?
1986
1986
The in vitro activity of CI-934, a new 4-quinolone, was determined against gram-positive and gram-negative bacteria. The MICs for… (More)
Is this relevant?
1986
1986
The rate of bactericidal activity of a new quinolone, CI-934, was compared with that of amoxicillin for 20 strains of… (More)
  • figure 1
Is this relevant?
1986
1986
CI-934 is a new broad-spectrum fluoroquinolone. We have studied its in vitro activity against 203 bacteria and compared it with… (More)
Is this relevant?
1986
1986
no. 82; Marcus, E.L., Heifetz, C.L.: CI-934, a new antistreptococcal quinolone in vitro and chemotherapeutic studies. 14th… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
1986
1986
The in-vitro antibacterial activity of nalidixic acid and the 4-quinolones, ciprofloxacin, norfloxacin, enoxacin, ofloxacin… (More)
Is this relevant?
1985
1985
CI-934 is a totally synthetic difluorinated quinolinecarboxylic acid with an ethyl-amino-methyl pyrrolidine side chain, which has… (More)
Is this relevant?